Tenaya Therapeutics, Inc. (TNYA)
0.6947
0.00 (0.00%)
USD |
NASDAQ |
Sep 03, 16:00
0.6947
0.00 (0.00%)
After-Hours: 18:28
Tenaya Therapeutics Free Cash Flow : -52.59M for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -52.59M |
| March 31, 2026 | -64.63M |
| December 31, 2025 | -68.88M |
| September 30, 2025 | -73.47M |
| June 30, 2025 | -77.86M |
| March 31, 2025 | -85.80M |
| December 31, 2024 | -91.53M |
| September 30, 2024 | -95.25M |
| June 30, 2024 | -98.88M |
| March 31, 2024 | -101.62M |
| December 31, 2023 | -103.31M |
| September 30, 2023 | -104.47M |
| Date | Value |
|---|---|
| June 30, 2023 | -112.44M |
| March 31, 2023 | -118.62M |
| December 31, 2022 | -125.05M |
| September 30, 2022 | -130.48M |
| June 30, 2022 | -120.52M |
| March 31, 2022 | -103.17M |
| December 31, 2021 | -85.93M |
| September 30, 2021 | -75.61M |
| June 30, 2021 | -63.64M |
| March 31, 2021 | -56.65M |
| December 31, 2020 | -45.21M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Intellia Therapeutics, Inc. | -348.69M |
| Arrowhead Pharmaceuticals, Inc. | -75.11M |
| Oncolytics Biotech, Inc. | -26.53M |
| Sangamo Therapeutics, Inc. | -90.46M |
| Sarepta Therapeutics, Inc. | 58.34M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -3.552M |
| Cash from Investing (Quarterly) | -0.159M |
| Cash from Financing (Quarterly) | 0.909M |
| Free Cash Flow Per Share (Quarterly) | -0.0171 |
| Free Cash Flow to Equity (Quarterly) | 2.457M |
| Free Cash Flow to Firm (Quarterly) | -3.711M |
| Free Cash Flow Yield | -39.18% |